New drugs for bowel cancer

This newer treatment approach, already in normal use for other types of cancer, should be suitable for up to 3 in 5 new Stage 2 and 3 bowel cancer patients. Cathy Gladwin, a bowel cancer survivor and patient advocate, says: Changing the order of treatment has led to a greater, positive impact on recovery from bowel cancer and is an

A new drug has shown promise in slowing the regrowth of tumours among some bowel cancer patients, according to new findings of a major trial

Chemotherapy for small bowel cancer​​ The drugs most commonly used to treat small bowel cancer are: fluorouracil (5FU) capecitabine (Xeloda)

New bowel cancer drug is found to be 100% effective An immunotherapy drug could spare bowel cancer patients the need for surgery and

This newer treatment approach, already in normal use for other types of cancer, should be suitable for up to 3 in 5 new Stage 2 and 3 bowel cancer patients. Cathy Gladwin, a bowel cancer survivor and patient advocate, says: Changing the order of treatment has led to a greater, positive impact on recovery from bowel cancer and is an

Chemotherapy for small bowel cancer​​ The drugs most commonly used to treat small bowel cancer are: fluorouracil (5FU) capecitabine (Xeloda)

This follows news in May when NICE also approved the use of drug pembrolizumab, which is available as a first line treatment for some people with advanced bowel cancer. Advanced bowel cancer is when cancer has spread to other parts of the body. Both of the new recommendations are for a type of targeted treatment called immunotherapy

Chemotherapy for small bowel cancer​​ The drugs most commonly used to treat small bowel cancer are: fluorouracil (5FU) capecitabine (Xeloda)

The latest advancement in immunotherapy for bowel cancer is a breakthrough drug which is used to treat metastatic bowel cancer in patients with a specific DNA